Diabetes mellitus and cardiothoracic surgical site infections.
Persons afflicted with diabetes mellitus compose over one fourth of patients undergoing cardiothoracic surgery and create a particular challenge to surgical and critical care practitioners. This paper reviews the impact of diabetes mellitus on cardiothoracic surgical site infection (SSI) risk, with specific attention to recent data regarding the role of perioperative hyperglycemia as well as the use of continuous insulin infusion for SSI risk reduction in the cardiothoracic surgical population.
Talbot
Thomas R
TR
Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37232, USA. tom.talbot@vanderbilt.edu
D006348:Cardiac Surgical Procedures / Q000009:adverse effects*; D048909:Diabetes Complications; D006801:Humans; D006943:Hyperglycemia / Q000150:complications; D007332:Insulin Infusion Systems; D012307:Risk Factors; D013312:Stress, Physiological / Q000150:complications; D013530:Surgical Wound Infection / Q000209:etiology* / Q000517:prevention & control; D019616:Thoracic Surgical Procedures / Q000009:adverse effects*